Regulation
Time to Take Some Bitcoin Chips Off the Table
Here's what has me nervous now.
How to Stop Skyrocketing Share Prices? Let's Count the Ways
I fully expect some new regulation to come down from the market action of the past two weeks.
Bright Cannabis Outlook Leads to Bigger Estimates for 2022
The fundamentals of the cannabis industry continue to improve.
As New Biden Regulations Move Forward, There's Fallout in Some Sectors
This looks like consolidation after a big run rather than a major shift in market character.
Let's Grade the Social Media Stocks
Was Monday's price action much ado about nothing?
Alibaba May Need Magic Tricks to Aid in Bottoming
The risk is that all the gains since March could be wiped out.
With Alibaba on the Ropes, I'll Take a Pass
My feeling is that if one is into speculation, one can trade names like BABA.
Korean Stocks Make Run at Doubling on Margin Trading Fever
Household debt in South Korea stands at 100% of GDP as Koreans borrow like mad to buy stocks in a red-hot market where short selling is banned.
Pending Law Covering Foreign Company U.S. Listings Isn't Discriminatory
An act to improve the accounting compliance of foreign U.S.-listed companies doesn't mention China, and doesn't need to.
Why I'm Selling Boeing Shares
The plan is to take off what was a successful trade and reduce the risk, leaving an investment in place somewhat composed of 'house money'.
2021 Won't Be Like 2020 for Big Tech
There are three key reasons to think next year won't be a good as this year has been for the tech giants.
Nikola Drama Drags Other SPAC Names Downhill, Too
The popularity of special purpose acquisition companies has gotten the attention of the SEC, and now we have questions over FMCI's merger.
I Wouldn't Back Up the Truck for Nikola Stock Right Now
While I like getting involved in volatility, I don't see any edge here, only the potential to see things go ... rolling down hill.
China's Kingold Jewelry Allegedly Used Fake Gold to Secure Huge Loans
Lenders to the Nasdaq-listed jewelry maker reportedly have discoverd that 83 tons of gold used to borrow billions appear to be copper alloy bars.
Acreage Probe Leads Company to Reform Massachusetts Deals
Cannabis player came under scrutiny for number of store licenses in state.
Jim Cramer: The Earth's New Cop? The Microsoft Protection Agency
While the president is pushing coal, this corporate giant is stepping up to cut the carbon cord.
Under Armour Loses Traction and Puts Chart Support Into Question
Shares of the shoe and apparel maker are reacting to reduced revenue guidance and word of government investigations into its accounting practices.
The Cannabis Sector and Its Dot-Com Like Meltdown
Black-market vaping has made the entire cannabis group toxic.
Have Those Once-Smoking Cannabis Stocks Burnt Down to a Bottom?
Several watchers and market players are deep in the weeds, tracking short action and key companies like Canopy Growth, trying to find out whether the industry has turned over a new leaf.
These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis
No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.
Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared
Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.
M&A Appetite in Pharma Has Proved Potent: Chart of the Day
With total deals trending toward hundreds of billions, investors may be eager to bet on who's next to be acquired.
Why Macy's Is at Risk of Losing Its Shirt
Earnings misses, bad planning, and product-line execution problems are all hitting the retailer, but it's the macro woes that will also hurt its competitors.
Earnings to Tell Whether Cannabis' High Growth Story Is Going to Pot
After a 2018 high, marijuana stocks are gaining popularity again, but which ones are producing the most green for investors? Here are the charts.
A Look at Mylan's New Post-Merger Management
What new management means for Mylan shareholders moving forward.
Mylan Jumps on Deal With Pfizer to Form New Company
Pfizer will combine its off-patent drug business with Mylan in the as-yet-to-be-named new company.
Alphabet Shares Soar After Excellent Earnings Results
A big jump in the market cap of Google's parent is in store thanks to an impressive second-quarter report.
Tesla Tanks as Profitability Problems Persist, Another Executive Exits
Volatility reigns once again at the electric carmaker, which is seeing JB Straubel depart as chief technology officer.
Interesting Small-Cap Charts Are Developing Into Earnings
Big-cap names have been driving the market, but some small-caps could make noise, too.
Feds Probe Tech, Mueller Speaks, Holy Guacamole and Now Hear NOW: Market Recon
Watch closely as the government opens a broad antitrust investigation into unidentified leading online technology platforms